Back

Novel risk model for predicting incident atrial fibrillation in patients at high cardiovascular risk receiving omega-3 fatty acid: sub-analysis from the STRENGTH randomized clinical trial

29 August 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Lipids: drug therapy Drug therapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Tom Kai Ming Wang

Auckland City Hospital, Auckland (New Zealand)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor C. Soh (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Professor L. Rallidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Doctor M. Bellomare (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Lipids: drug therapy

The Event

Event poster

ESC Congress 2025

29 August 2025 12:30 CET
You may be interested in
thumbnail
Congress Session
Stroke prediction in atrial fibrillation
29 August 2025
thumbnail
Congress Presentation
Predicting atrial fibrillation in heart failure: added value of a plasma protein risk score over clinical and genomic models
12 April 2026
thumbnail
Congress Presentation
Fish oil supplements increase atrial fibrillation risk in healthy individuals: a population-based cohort study and mendelian randomization analysis
29 August 2022
thumbnail
Congress Presentation
A systematic review and meta-analysis on the predictive value of the C2HEST score to predict new onset atrial fibrillation in >11 million Western and Asian subjects.
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources